Company issues recall of some EpiPen, EpiPen Jr. devices

The company behind EpiPen and EpiPen Jr. is voluntarily recalling some of its products due to a defect that may keep the lifesaving devices from working.

On Friday, the U.S. Food and Drug Administration alerted the public to Meridian Medical Technologies' voluntary recall of 13 lots of the EpiPen and EpiPen Jr. Auto-Injector Products because of a defective part.

The devices, distributed by Mylan Specialty and used as an emergency treatment of severe allergic reactions, are being recalled because the defect may prevent the devices from activating.

So far, 13 lots distributed between Dec. 17, 2015 and July 1, 2016 have been identified and are the only lots impacted by the recall and will need to be replaced.

Lots included the following:

Product/Dosage

NDC Number

Lot Number

Expiration Date

EpiPen Jr Auto-Injector, 0.15 mg

49502-501-02

5GN767

April 2017

EpiPen Jr Auto-Injector, 0.15 mg

49502-501-02

5GN773

April 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

5GM631

April 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

5GM640

April 2017

EpiPen Jr Auto-Injector, 0.15 mg

49502-501-02

6GN215

September 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM082

September 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM072

September 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM081

September 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM088

October 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM199

October 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM091

October 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM198

October 2017

EpiPen Auto-Injector, 0.3 mg

49502-500-02

6GM087

October 2017

 

© 2017 WXIA-TV


JOIN THE CONVERSATION

To find out more about Facebook commenting please read the
Conversation Guidelines and FAQs

Leave a Comment